Assessment of the best loading dose of clopidogrel to blunt platelet activation, inflammation and ongoing necrosis.

Trial Profile

Assessment of the best loading dose of clopidogrel to blunt platelet activation, inflammation and ongoing necrosis.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Sep 2006

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Thrombosis
  • Focus Pharmacodynamics
  • Sponsors Sanofi
  • Most Recent Events

    • 13 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top